Weighted Average Number of Shares Outstanding, Basic of Cytosorbents Corp from Q2 2014 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cytosorbents Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2014 to Q3 2025.
  • Cytosorbents Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 62.8M shares, a 15.2% increase year-over-year.
  • Cytosorbents Corp annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 54.4M shares, a 21.9% increase from 2023.
  • Cytosorbents Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 44.7M shares, a 2.49% increase from 2022.
  • Cytosorbents Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 43.6M shares, a 0.49% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Cytosorbents Corp Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 62.8M +8.3M +15.2% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 62.6M +8.3M +15.3% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 60.7M +6.3M +11.6% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 54.4M +9.78M +21.9% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 54.5M +10.1M +22.7% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 54.3M +10.3M +23.4% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 54.4M +10.8M +24.6% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 44.7M +1.08M +2.49% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 44.4M +767K +1.76% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 44M +455K +1.04% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 43.7M +188K +0.43% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 43.6M +214K +0.49% 01 Oct 2022 31 Dec 2022 10-K 15 Mar 2024
Q3 2022 43.6M +211K +0.49% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 43.6M +243K +0.56% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023
Q1 2022 43.5M +245K +0.57% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 43.4M 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2024
Q3 2021 43.4M +1.8M +4.34% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 43.3M 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 43.2M 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q3 2020 41.6M 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2016 25.4M +647K +2.61% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2016
Q2 2015 24.8M +12.7M +106% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q2 2014 12M 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015

Cytosorbents Corp Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 54.4M +9.78M +21.9% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 44.7M +1.08M +2.49% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 43.6M +214K +0.49% 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2024
2021 43.4M +4.54M +11.7% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2024
2020 38.8M +6.56M +20.3% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2023
2019 32.3M 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.